The Drug Delivery and Biomaterials Group, School of Pharmacy, Medical Biology Centre, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, Northern Ireland, UK.
J Pharm Sci. 2010 Mar;99(3):1322-35. doi: 10.1002/jps.21914.
Solid molecular dispersions of bicalutamide (BL) and polyvinylpyrrolidone (PVP) were prepared by hot melt extrusion technology at drug-to-polymer ratios of 1:10, 2:10, and 3:10 (w/w). The solid-state properties of BL, physical mixtures of BL/PVP, and hot melt extrudates were characterized using differential scanning calorimetry (DSC), powder X-ray diffractometry (PXRD), Raman, and Fourier transform infrared (FTIR) spectroscopy. Drug dissolution studies were subsequently conducted on hot melt extruded solid dispersions and physical mixtures. All hot melt extrudates had a single T(g) between the T(g) of amorphous BL and PVP indicating miscibility of BL with PVP and the formation of solid molecular dispersions. PXRD confirmed the presence of the amorphous form of BL within the extrudates. Conversely, PXRD patterns recorded for physical mixtures showed sharp bands characteristic of crystalline BL, whereas DSC traces had a distinct endotherm at 196 degrees C corresponding to melting of crystalline BL. Further investigations using DSC confirmed solid-state plasticization of PVP by amorphous BL and hence antiplasticization of amorphous BL by PVP. Experimentally observed T(g) values of physical mixtures were shown to be significantly higher than those calculated using the Gordon-Taylor equation suggesting the formation of strong intermolecular interactions between BL and PVP. FTIR and Raman spectroscopy were used to investigate these interactions and strongly suggested the presence of secondary interaction between PVP and BL within the hot melt extrudates. The drug dissolution properties of hot melt extrudates were enhanced significantly in comparison to crystalline BL and physical mixtures. Moreover, the rate and extent of BL release were highly dependent on the amount of PVP present within the extrudate. Storage of the extrudates confirmed the stability of amorphous BL for up to 12 months at 20 degrees C, 40% RH whereas stability was reduced under highly humid conditions (20 degrees C, 65% RH). Interestingly, BL recrystallization after storage under these conditions had no effect on the dissolution properties of the extrudates.
采用热熔挤出技术,在药物与聚合物比例为 1:10、2:10 和 3:10(w/w)的情况下,制备了比卡鲁胺(BL)和聚乙烯吡咯烷酮(PVP)的固体分子分散体。使用差示扫描量热法(DSC)、粉末 X 射线衍射(PXRD)、拉曼和傅里叶变换红外(FTIR)光谱对 BL、BL/PVP 物理混合物和热熔挤出物的固态特性进行了表征。随后对热熔挤出的固体分散体和物理混合物进行了药物溶出研究。所有热熔挤出物在无定形 BL 和 PVP 的 Tg 之间均具有单个 Tg,表明 BL 与 PVP 具有混溶性,并形成了固体分子分散体。PXRD 证实了挤出物中存在无定形 BL 形式。相反,物理混合物的 PXRD 图谱显示出结晶 BL 的特征尖锐带,而 DSC 迹线在 196 度处具有明显的吸热峰,对应于结晶 BL 的熔融。进一步使用 DSC 进行的研究证实了无定形 BL 对 PVP 的固态塑化作用,以及 PVP 对无定形 BL 的反塑化作用。实验观察到的物理混合物的 Tg 值明显高于使用 Gordon-Taylor 方程计算的值,这表明 BL 和 PVP 之间形成了强的分子间相互作用。FTIR 和拉曼光谱用于研究这些相互作用,并强烈表明热熔挤出物中 PVP 和 BL 之间存在次级相互作用。与结晶 BL 和物理混合物相比,热熔挤出物的药物溶出性能得到了显著提高。此外,BL 释放的速率和程度高度依赖于挤出物中 PVP 的含量。在 20 摄氏度、40%相对湿度下储存挤出物 12 个月,可确保无定形 BL 的稳定性,而在高湿度条件(20 摄氏度、65%相对湿度)下,稳定性降低。有趣的是,在这些条件下储存后 BL 再结晶对挤出物的溶解性能没有影响。